Increased acetylcholinesterase activity in selected regions of rat brain after chronic (-)-deprenyl administration

Neurochemical Research

Volumn 21, Issue 10, 1996, Pages 1209-1212

  Lakshmana, Madepalli K ^a   Jagadeesh, S ^a   Subhash, M N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

( ) Deprenyl; AChE; MAO A; MAO B; rat brain regions

Indexed keywords

ACETYLCHOLINESTERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; SELEGILINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN METABOLISM; BRAIN STEM; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME LOCALIZATION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; BRAIN MAPPING; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, WISTAR; SELEGILINE; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0029858887     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02532397     Document Type: Article

References (17)

1. Parkinson study group. 1993. Effect of tocopherol and (-) deprenyl to the progression of disability in early Parkinson's disease. N. Engl. J. Med. 328:176-183.
2. Piccinin, G. L., Finali, G., and Piccirilli, M. 1990. Neuropsychological effects of L-deprenyl in Alzheimer's type dementia. Clin. Neuropharmacology 13:147-163.
3. Mann, J. J., Aarons, S. F., and Wilner, P. J. 1989. A controlled study of the antidepressant efficacy and side effects of (-) deprenyl. Arch. Gen. Psychiatry 46:45-54.
4. Finnegan, K. T., Skratt, J. J., Irwin, I., De Lanney, L. E., and Langston, J. W. 1990. Protection against DSP-4 induced neurotoxicity by (-) deprenyl is not related to its inhibition of MAO-B. Eur. J. Pharmacol. 184:119-126.
5. Kitani, S., Kanai, S., Sato, Y., Ohta, M., Ivy, G. O., and Carrillo, M-C. 1992. Chronic treatment of (-) deprenyl prolongs the life span of male Fisher 344 rats. Further evidence Life Sci. 52:281-288.
6. Knoll, J. 1988. The striatal dopamine dependency of life span in male rats. Longevity with (-) deprenyl. Mech. Aging Dev. 46:237-242.
7. Knoll, J., and Miklya, Y. N. 1994. Sexually low performing male rats die earlier than their high performing peers and (-) deprenyl treatment eliminates this difference. Life Sci. 54:1047-1057.
8. Piccinin, G. L., Finali, G., and Piccirilli, M. 1990. Neuropsychological effects of L-deprenyl in Alzheimers type dementia. Clin. Neuropharmacology 13:147-163.
9. Tariot, P. N., Sunderland, T., Weingarther, H., Murphy, D. L., Welkowitz, J. A., Thompson K., and Cohen, R. M. 1987. Cognitive effects of L-deprenyl in Alzheimer's disease. Psychopharmacology 91:489-495.
10. Peterson, I. A., Juorio, A. V., Berry, M. D., and Zhu, M. Y. 1991. Inhibition of monoamine oxidase-B by (-) deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in rat striatum. J. Pharmacol. Exp. Therap. 258:1019-1026.
11. Cohen, G., and Spina, M. B. 1989. (-) Deprenyl suppresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26:689-690.
12. Langston, J. W. 1988. Pages 75-85 in Jankevic J (ed.) Parkinson's disease and movement disorders. Baltimore, urban and schwarzenberg.
13. Carrillo, M. C., Kanai, S., Nokubo, M., Ivy, G. V., Sato, Y., and Kitani. K. 1992. (-) Deprenyl increases activities of Superoxide dismutase and catalase in striatum but not hippocampus: The sex and age related differences in the optimal dose in the rat. Exp. Neurol. 116:286-294.
14. Inestrosa, N. C. and Sato, C. 1992. Molecular biology of the amyloid of Alzheimer's disease: an overview. Biol. Res. 25:63-72.
15. Dunnett, S. B. and Fibiger, H. C. 1993. Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia. In Cholinergic function and dysfunction. Progress in Brain Research, (ed. Cuello, A. C.) pp 413-420, Elsevier, Amsterdam.
16. Fishman, E. B., Siek, G. C., Mc Callum, R. D., Bird, E. D., Volicer, L. and Marquis, J. K. 1986. Distribution of the molecular forms of acetyl cholinesterase in human brain: alterations in dementia of the Alzheimer's type. Ann. Neurol. 19:246-252.
17. Lindgren, S., Anden N. E. and Anden, M. G. 1982. A fluorometric method for determination of GABA in tissues following cation exchange chromatography and condensation with 0- phthalaldehyde. J. Neural Transm. 55:243-252.